BMY vs TECH: Options Risk Comparison

BRISTOL MYERS SQUIBB CO and BIO-TECHNE Corp compared side by side — risk score, IV Rank, edge and earnings. Updated every 30 minutes.

Metric	BMY	TECH
Risk Score	44	94
Risk Band	LOW	HIGH
IV Rank	50.5%	0.1%
IV %	29.8%	55.3%
Edge Score	+6	-94
Price Δ	+0.5%	+0.1%
Next Earnings	2026-07-30	2026-08-05
Sector	Health Care	Health Care

Which has higher options risk?

BIO-TECHNE Corp (TECH) currently carries the higher options risk score (94 vs 44 for BMY) — meaning more active catalysts that can drive an overnight move. For selling option premium, BRISTOL MYERS SQUIBB CO (BMY) has the better edge score (+6) — a stronger blend of high IV Rank and low risk.

Risk score (0–100) reflects active catalysts — earnings, legal, SEC filings and news. Edge score = IV Rank − risk score; higher is better for selling premium.

Run a full scan on each — free

Scan BMY → Scan TECH →

BMY risk pages

BMY overview BMY IV / options BMY earnings TECH overview TECH IV / options TECH earnings

More Health Care comparisons

BMY vs ABT BMY vs ABBV BMY vs A BMY vs ALGN BMY vs AMGN BMY vs BAX BMY vs BDX BMY vs BIIB

TickerRisk provides risk scoring for informational purposes only. Not financial advice. Options trading involves substantial risk of loss. Full disclaimer